Navigation Links

Tag: "psa" at medical news

Capsaicin patches help reduce post-shingles pain

Researchers at the University of Wisconsin have reported that those who suffer..from post-herpetic neuralgia or pain following an attack of shingles can now get..relief through a patch of Capsaicin, the active ingredient of chili peppers...Shingles is caused the varicella zoster virus, which also causes chicken pox...Shingles results in the occurrence of painful rashes on one side of the body and...

Body Weight Found To Influence PSA Levels

A new study shows obese men generally have lower prostate specific antigen levels than men of normal weight. // However researchers say this finding suggests the PSA test may not be as good at identifying early prostate cancer in such men. ..Researchers studied about 2,800 men with no evidence of prostate cancer. Results showed PSA levels declined as weight increased. The association held true ac...

Sudden Rise in PSA Dangerous for men

Prostate cancer is the second-leading cause of cancer death in men and kills nearly 30,000 men each year. The lifetime risk of being diagnosed, one in six, is higher than the one in eight risk of breast cancer in women. // A new study shows the rate of rise in prostate-specific antigen levels, or PSA velocity, before prostate cancer diagnosis is a more powerful indicator of eventual death from pr...

Annual PSA screening reduces risk of prostate cancer deaths

Findings presented at the American Society of Therapeutic Radiation Oncology (ASTRO) reveal that yearly screening for prostate specific antigen (PSA) // significantly reduces the mortality associated with prostate cancer. ..Prostate cancer is the second most prevalent type of cancer found in men after skin cancer. The prostate itself is a small gland in the male reproductive system, which produc...

Age Can Affect PSA Reading And Prostate Cancer Diagnosis

Prostate specific antigen is a tumor marker, elevated level of which is strongly suggestive of prostate cancer in men. PSA testing is routinely used by doctors to spot early signs of prostate cancer, // if any. A new study has now suggested that a different criterion may be needed for establishment of prostate cancer diagnosis in young men and those above 70 years of age. ....The researchers fr...

PSA Can Predicts The Treatment Response In Advanced Prostate Cancer

A new study that has been conducted by researchers from the University of Michigan (U-M) medical school states that patients with lower PSA levels, //7 months after therapy lived longer. ....According to a new multicentre study that has been conducted by the Southwest Oncology Group and led by researchers at the U-M Comprehensive Cancer Centre, that has been published in the August 20th issue of...

Hair-Growth Drug Artificially Lowers Psa Levels in Prostate Cancer Screening

The popular hair-growth drug finasteride, taken by millions of balding men, artificially lowers the results of the prostate-specific antigen (PSA) test,// the standard screening test for prostate cancer, a multicenter study has found. ....The study, involving 308 men ranging in age from 40 to 60 years old, is available online in the British medical journal The Lancet and is scheduled to be publis...

PSA Not a Good Predictor of Lethal Prostate Cancer

The amount of prostate-specific antigen (PSA) in a man’s bloodstream at the time of his prostate cancer diagnosis or its rate of change over the course of the disease// does not adequately predict lethal prostate cancer, according to a study in the April 4 Journal of the National Cancer Institute. ....Although men with untreated localized prostate cancer have high long-term survival rates, many...

PSA Doubling Predicts Prostate Cancer Recurrence

A detectable level of prostate-specific antigen (PSA) is the first indicator of recurrent prostate cancer after radical// prostatectomy. ....In a new Mayo Clinic study, the concept of PSA doubling time (DT) is found to be a reliable tool to distinguish which patients have prolonged innocuous PSA levels after therapy from those who are at great risk for disease recurrence and death from prostate...

High Pretreatment PSA Velocity Predicts Worse Outcome

The most significant single predictor of aggressive prostate cancer is an elevated rate of increase in prostate specific antigen (PSA) levels, according to a new study. The study found that a pre-treatment rate of PSA increase, called PSA velocity, of more than 2 ng/ml/year was strongly associated with a high risk of death from prostate cancer. Elevated PSA velocity was a stronger poor prognosti...
Other Tags
(Date:7/29/2015)... CA (PRWEB) , ... July 29, 2015 , ... We are privileged to announce that ... Medicine of USC as the ninth best ophthalmology hospital in the nation for 2015-2016. This ... 10 American hospitals for ophthalmology. , “It is an honor to be included in ...
(Date:7/29/2015)... ... July 29, 2015 , ... Inspired by a successful ... Steven W. Meier M.D., a prominent orthopedic surgeon and regenerative medicine expert in ... financial need. , “We are thrilled for this opportunity to offer prolotherapy treatments ...
(Date:7/29/2015)... ... July 29, 2015 , ... Stealth ... a Clinical Performance Study for the Invisiport at Wheaton Franciscan Healthcare in Milwaukee, ... options, offers a less invasive, patient-friendly alternative to traditional chest ports and peripherally ...
(Date:7/29/2015)... ... July 29, 2015 , ... Zofran ... Judicial Panel on Multidistrict Litigation (JPML), according to court documents.* Attorneys handling ... website, the Zofran Birth Defects Lawsuit Center. , GlaxoSmithKline, the global pharmaceutical conglomerate ...
(Date:7/29/2015)... ... July 29, 2015 , ... The Woodlands and Spring ... lifestyles while donating to worthy charitable causes each month. The new system will track ... camp. For each Check In at each facility, the boot camps will donate 20 ...
Breaking Medicine News(10 mins):Health News:21 Years & Counting: The USC Eye Institute Ranks in the Top 10 Ophthalmology Hospitals in America 2Health News:21 Years & Counting: The USC Eye Institute Ranks in the Top 10 Ophthalmology Hospitals in America 3Health News:Orthopedic Surgeon Announces New Pro Bono Prolotherapy and Regenerative Medicine Clinic for Underserved Communities in Los Angeles 2Health News:Stealth Therapeutics Inc. Enrolls First Patients in a Clinical Performance Study for the Invisiport Product Line 2Health News:Stealth Therapeutics Inc. Enrolls First Patients in a Clinical Performance Study for the Invisiport Product Line 3Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 2Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 3Health News:Zofran Lawsuit News: Zofran Lawsuits Stayed, Awaiting MDL Decision 4Health News:Transforming Texan Lives and Bodies: Woodlands and Spring Fitness Boot Camps Commit to Multiple Charity Donations 2Health News:Transforming Texan Lives and Bodies: Woodlands and Spring Fitness Boot Camps Commit to Multiple Charity Donations 3
(Date:7/21/2015)... , July 21, 2015 Today, ZTE announced ... received as well as expected revenues in 2015 that relate to ... communicated revenue guidance of approximately 2,200 MSEK for 2015. ... a leading smartphone manufacturer in China and ... 02 5 for Axon , ...
(Date:7/13/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... focused on the growing mobile commerce market, announced ... for BEHAVIORAL-DIRECTED AUTHENTIATION METHOD AND SYSTEM. ... secure method to make payments.  With this patent, ... with its groundbreaking voice-direct payment patent application, with ...
(Date:7/8/2015)... 2015 Summary Pancreatic cancer is the ... fatal, with a mortality rate of 10.9 deaths per ... cancer patients has highlighted a significant need for new ... met by the current market. A highly active ... varying molecule types and mechanisms of action, which provides ...
Breaking Biology News(10 mins):FPC's Touch Fingerprint Sensor FPC1025 in ZTE's Smartphone Axon 2NXT-ID Patents Behavior-Directed Payments 2NXT-ID Patents Behavior-Directed Payments 3NXT-ID Patents Behavior-Directed Payments 4Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3
Other Contents